Search Results - "Kaewdech, Apichat"

Refine Results
  1. 1

    Effect of smartphone-assisted lifestyle intervention in MASLD patients: a randomized controlled trial by Kaewdech, Apichat, Assawasuwannakit, Suraphon, Churuangsuk, Chaitong, Chamroonkul, Naichaya, Sripongpun, Pimsiri

    Published in Scientific reports (17-06-2024)
    “…Metabolic dysfunction-associated steatotic liver disease (MASLD) is emerging globally as a significant problem. The mainstay of treatment is lifestyle…”
    Get full text
    Journal Article
  2. 2

    HBV seroprevalence and liver fibrosis status among population born before national immunization in Southern Thailand: Findings from a health check-up program by Sono, Supinya, Sae-Chan, Jirayu, Kaewdech, Apichat, Chamroonkul, Naichaya, Sripongpun, Pimsiri

    Published in PloS one (24-06-2022)
    “…Background Hepatitis B virus (HBV) infection is the leading cause of liver-related death worldwide, particularly in Asia. Patients with either current or past…”
    Get full text
    Journal Article
  3. 3

    Lyophilized cell-free supernatants of Limosilactobacillus fermentum T0701 exhibited antibacterial activity against Helicobacter pylori by Sornsenee, Phoomjai, Surachat, Komwit, Wong, Thanawin, Kaewdech, Apichat, Saki, Morteza, Romyasamit, Chonticha

    Published in Scientific reports (13-06-2024)
    “…Helicobacter pylori is a prominent gastrointestinal pathogen associated with various gastrointestinal illnesses. It presents substantial health risks due to…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Utility of handgrip strength (HGS) and bioelectrical impedance analysis (BIA) in the diagnosis of sarcopenia in cirrhotic patients by Luengpradidgun, Lalida, Chamroonkul, Naichaya, Sripongpun, Pimsiri, Kaewdech, Apichat, Tanutit, Pramot, Ina, Natee, Piratvisuth, Teerha

    Published in BMC gastroenterology (30-03-2022)
    “…Sarcopenia is associated with disability, mortality, and poorer survival in cirrhotic patients. For the evaluation of muscle volume, computed tomography (CT)…”
    Get full text
    Journal Article
  9. 9

    Coronavirus Disease 2019 Vaccinations in Patients With Chronic Liver Disease and Liver Transplant Recipients: An Update by Sripongpun, Pimsiri, Pinpathomrat, Nawamin, Bruminhent, Jackrapong, Kaewdech, Apichat

    Published in Frontiers in medicine (22-06-2022)
    “…Coronavirus disease 2019 (COVID-19) is a current global pandemic associated with an increased mortality, particularly in patients with comorbidities. Patients…”
    Get full text
    Journal Article
  10. 10
  11. 11

    The effect of fiber supplementation on the prevention of diarrhea in hospitalized patients receiving enteral nutrition: A meta-analysis of randomized controlled trials with the GRADE assessment by Kaewdech, Apichat, Sripongpun, Pimsiri, Wetwittayakhlang, Panu, Churuangsuk, Chaitong

    Published in Frontiers in nutrition (Lausanne) (25-11-2022)
    “…Enteral nutrition (EN) in hospitalized patients has several advantages. However, post-feeding diarrhea occurs frequently and has been linked to negative…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Exacerbation of Autoimmune Hepatitis following Inactivated SARS-CoV-2 Vaccination by Nawalerspanya, Siwanon, Wongseree, Kontee, Sripongpun, Pimsiri, Chamroonkul, Naichaya, Kaewdech, Apichat

    “…Autoimmune hepatitis (AIH) is a rare condition that has seldom been reported being reactivated by a coronavirus disease 2019 (COVID-19) vaccination, especially…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Prevalence and virulence factors of Helicobacter pylori isolated from oral cavity of non-disease, gastritis, and gastric cancer patients by Wongsuwanlert, Mutita, Teanpaisan, Rawee, Pahumunto, Nuntiya, Kaewdech, Apichat, Ruangsri, Praphansri, Sunpaweravong, Somkiat

    Published in Journal of dental sciences (01-04-2024)
    “…The oral cavity is considered a reservoir of Helicobacter pylori associated with gastric infection. It aimed to examine the prevalence of H. pylori strains…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score by Sripongpun, Pimsiri, Kaewdech, Apichat, Udompap, Prowpanga, Kim, W. Ray

    Published in JHEP reports (01-10-2024)
    “…The new nomenclature of steatotic liver disease (SLD) was recently launched with sub-classifications of metabolic dysfunction-associated SLD (MASLD), MASLD…”
    Get full text
    Journal Article
  19. 19

    FAIL-T (AFP, AST, tumor sIze, ALT, and Tumor number): a model to predict intermediate-stage HCC patients who are not good candidates for TACE by Kaewdech, Apichat, Sripongpun, Pimsiri, Assawasuwannakit, Suraphon, Wetwittayakhlang, Panu, Jandee, Sawangpong, Chamroonkul, Naichaya, Piratvisuth, Teerha

    Published in Frontiers in medicine (02-05-2023)
    “…Patients with un-resectable hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE) are a diverse group with varying overall…”
    Get full text
    Journal Article
  20. 20

    Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion: a randomized controlled trial by Keeratichananont, Warangkana, Kaewdech, Apichat, Keeratichananont, Suriya

    “…Background: Autologous blood is a novel, high-efficacy sclerosant for treatment of malignant pleural effusion (MPE), similar to tetracycline. There has been no…”
    Get full text
    Journal Article